| Caleb Heath, NP-C | |
|
975 E 3rd St Ste C-830, Chattanooga, TN 37403-2147 | |
| (423) 778-9001 | |
| Not Available |
| Full Name | Caleb Heath |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 975 E 3rd St Ste C-830, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013388404 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 20495 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Chattanooga | Chattanooga, TN | Home health agency |
| Erlanger Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chattanooga Hamilton County Hospital Authority | 0547179731 | 156 |
| Erlanger Health | 1153780226 | 352 |
News Archive
Today's headlines include reports regarding the gathering storm as the White House and GOP lawmakers continue to hold firm in their positions regarding the looming debt limit. President Barack Obama says he won't negotiate while some Republicans are pushing for to defund, or at least delay, the health law's implementation.
A new brief, 5-question screening tool can help clinicians identify which veterans may be at greater risk of violence, according to a new study led by a UNC researcher.
The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines.
Working with lab animals and human heart cells, scientists from Johns Hopkins and other institutions have identified what they describe as "the long-sought culprit" in the mystery behind a cell-signaling breakdown that triggers heart failure. The condition, which affects nearly 6 million Americans and 23 million people worldwide, is marked by progressive weakening and stiffening of the heart muscle and the organ's gradual loss of blood-pumping ability.
› Verified 6 days ago
| Entity Name | Chattanooga Hamilton County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154751931 PECOS PAC ID: 0547179731 Enrollment ID: O20040302001086 |
News Archive
Today's headlines include reports regarding the gathering storm as the White House and GOP lawmakers continue to hold firm in their positions regarding the looming debt limit. President Barack Obama says he won't negotiate while some Republicans are pushing for to defund, or at least delay, the health law's implementation.
A new brief, 5-question screening tool can help clinicians identify which veterans may be at greater risk of violence, according to a new study led by a UNC researcher.
The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines.
Working with lab animals and human heart cells, scientists from Johns Hopkins and other institutions have identified what they describe as "the long-sought culprit" in the mystery behind a cell-signaling breakdown that triggers heart failure. The condition, which affects nearly 6 million Americans and 23 million people worldwide, is marked by progressive weakening and stiffening of the heart muscle and the organ's gradual loss of blood-pumping ability.
› Verified 6 days ago
| Entity Name | Erlanger Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477256303 PECOS PAC ID: 1153780226 Enrollment ID: O20230707000849 |
News Archive
Today's headlines include reports regarding the gathering storm as the White House and GOP lawmakers continue to hold firm in their positions regarding the looming debt limit. President Barack Obama says he won't negotiate while some Republicans are pushing for to defund, or at least delay, the health law's implementation.
A new brief, 5-question screening tool can help clinicians identify which veterans may be at greater risk of violence, according to a new study led by a UNC researcher.
The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines.
Working with lab animals and human heart cells, scientists from Johns Hopkins and other institutions have identified what they describe as "the long-sought culprit" in the mystery behind a cell-signaling breakdown that triggers heart failure. The condition, which affects nearly 6 million Americans and 23 million people worldwide, is marked by progressive weakening and stiffening of the heart muscle and the organ's gradual loss of blood-pumping ability.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Caleb Heath, NP-C 975 E 3rd St Ste C-830, Chattanooga, TN 37403-2147 Ph: (423) 778-9001 | Caleb Heath, NP-C 975 E 3rd St Ste C-830, Chattanooga, TN 37403-2147 Ph: (423) 778-9001 |
News Archive
Today's headlines include reports regarding the gathering storm as the White House and GOP lawmakers continue to hold firm in their positions regarding the looming debt limit. President Barack Obama says he won't negotiate while some Republicans are pushing for to defund, or at least delay, the health law's implementation.
A new brief, 5-question screening tool can help clinicians identify which veterans may be at greater risk of violence, according to a new study led by a UNC researcher.
The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines.
Working with lab animals and human heart cells, scientists from Johns Hopkins and other institutions have identified what they describe as "the long-sought culprit" in the mystery behind a cell-signaling breakdown that triggers heart failure. The condition, which affects nearly 6 million Americans and 23 million people worldwide, is marked by progressive weakening and stiffening of the heart muscle and the organ's gradual loss of blood-pumping ability.
› Verified 6 days ago
Cindy T Gilbert, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1200 Pineville Rd, Chattanooga, TN 37405 Phone: 423-265-0063 Fax: 423-263-1060 | |
Mrs. Marjorie Menardy Magloire, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1508 Tombras Ave, Chattanooga, TN 37412 Phone: 423-867-4969 | |
Ms. Sandra Candece Huggins, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1949 Gunbarrel Rd Ste 200, Chattanooga, TN 37421 Phone: 423-498-5980 Fax: 423-498-5981 | |
Misty Gilliland, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1726 Gunbarrel Rd Ste 100, Chattanooga, TN 37421 Phone: 423-954-9010 Fax: 423-510-8561 | |
Lauren A Fox, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 900 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-5437 | |
Lisa Kahana-naipo, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 725 Glenwood Dr Ste E786, Chattanooga, TN 37404 Phone: 423-682-8150 Fax: 423-682-8151 | |
Elizabeth North Fluhrer, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2515 Desales Ave Ste 206, Chattanooga, TN 37404 Phone: 423-698-8101 Fax: 423-698-3450 |